Advances in melanoma: epidemiology, diagnosis, and prognosis
- PMID: 38076247
- PMCID: PMC10703395
- DOI: 10.3389/fmed.2023.1268479
Advances in melanoma: epidemiology, diagnosis, and prognosis
Abstract
Unraveling the multidimensional complexities of melanoma has required concerted efforts by dedicated community of researchers and clinicians battling against this deadly form of skin cancer. Remarkable advances have been made in the realm of epidemiology, classification, diagnosis, and therapy of melanoma. The treatment of advanced melanomas has entered the golden era as targeted personalized therapies have emerged that have significantly altered the mortality rate. A paradigm shift in the approach to melanoma classification, diagnosis, prognosis, and staging is underway, fueled by discoveries of genetic alterations in melanocytic neoplasms. A morphologic clinicopathologic classification of melanoma is expected to be replaced by a more precise molecular based one. As validated, convenient, and cost-effective molecular-based tests emerge, molecular diagnostics will play a greater role in the clinical and histologic diagnosis of melanoma. Artificial intelligence augmented clinical and histologic diagnosis of melanoma is expected to make the process more streamlined and efficient. A more accurate model of prognosis and staging of melanoma is emerging based on molecular understanding melanoma. This contribution summarizes the recent advances in melanoma epidemiology, classification, diagnosis, and prognosis.
Keywords: melanoma; melanoma classification; melanoma diagnosis; melanoma epidemiology; melanoma genomics.
Copyright © 2023 Waseh and Lee.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Histopathologic classification and prognostic factors of melanoma: a 2021 update.Ital J Dermatol Venerol. 2021 Jun;156(3):300-321. doi: 10.23736/S2784-8671.21.06958-3. Epub 2021 May 13. Ital J Dermatol Venerol. 2021. PMID: 33982546 Review.
-
Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy Prediction.Int J Mol Sci. 2022 May 11;23(10):5384. doi: 10.3390/ijms23105384. Int J Mol Sci. 2022. PMID: 35628196 Free PMC article. Review.
-
Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.Pathology. 2016 Feb;48(2):113-31. doi: 10.1016/j.pathol.2015.12.007. Epub 2016 Jan 18. Pathology. 2016. PMID: 27020384 Free PMC article. Review.
-
Association Between Confocal Morphologic Classification and Clinical Phenotypes of Multiple Primary and Familial Melanomas.JAMA Dermatol. 2016 Oct 1;152(10):1099-1105. doi: 10.1001/jamadermatol.2016.1189. JAMA Dermatol. 2016. PMID: 27579522
-
Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.Clin Cancer Res. 2018 Sep 15;24(18):4494-4504. doi: 10.1158/1078-0432.CCR-18-0763. Epub 2018 Jun 11. Clin Cancer Res. 2018. PMID: 29891723
Cited by
-
Tessaria absinthioides (Hook. & Arn.) DC. Determines Inhibition of Tumor Growth and Metastasis In Vitro and In Vivo in Murine Melanoma.Plants (Basel). 2025 May 2;14(9):1379. doi: 10.3390/plants14091379. Plants (Basel). 2025. PMID: 40364408 Free PMC article.
-
Tumor Vaccines for Malignant Melanoma: Progress, Challenges, and Future Directions.Oncol Res. 2025 Jul 18;33(8):1875-1893. doi: 10.32604/or.2025.063843. eCollection 2025. Oncol Res. 2025. PMID: 40746887 Free PMC article. Review.
-
Angiogenesis Still Plays a Crucial Role in Human Melanoma Progression.Cancers (Basel). 2024 May 8;16(10):1794. doi: 10.3390/cancers16101794. Cancers (Basel). 2024. PMID: 38791873 Free PMC article. Review.
-
Association between triglyceride‑glucose index as a marker of insulin resistance and the risk of malignant melanoma: A retrospective study.Oncol Lett. 2025 Feb 7;29(4):173. doi: 10.3892/ol.2025.14919. eCollection 2025 Apr. Oncol Lett. 2025. PMID: 39968015 Free PMC article.
-
Atractylenolide I inhibits the growth, proliferation and migration of B16 melanoma cells via the PI3K/AKT/mTOR pathway.Oncol Lett. 2025 May 30;30(2):372. doi: 10.3892/ol.2025.15118. eCollection 2025 Aug. Oncol Lett. 2025. PMID: 40503042 Free PMC article.
References
-
- SEER . (n.d.) Melanoma of the Skin – Cancer stat facts. SEER web site. Available at: https://seer.cancer.gov/statfacts/html/melan.html (Accessed July 9, 2023)
-
- American Cancer Society . (2023) Melanoma skin Cancer statistics. Available at: https://www.cancer.org/cancer/types/melanoma-skin-cancer/about/key-stati... (Accessed July 9, 2023)
Publication types
LinkOut - more resources
Full Text Sources
Research Materials